USA – Trump Nominates Hahn to be FDA Commissioner

President Donald Trump on Friday nominated Stephen Hahn, chief medical executive of the MD Anderson Cancer Center in Houston, to be the next US Food and Drug Administration (FDA) commissioner.

If confirmed by the Senate, a process that could take several months, Hahn will take the reins of FDA from Acting Commissioner Ned Sharpless, who moved over to FDA following a stint as head of the National Cancer Institute (NCI). Sharpless will return to direct NCI, while Brett Giroir, assistant secretary for health at the US Department of Health and Human Services (HHS), will serve as acting FDA commissioner while Hahn’s confirmation process occurs.

Hahn, also a former NCI alum in the early 1990s, previously served as chair of the Radiation Oncology Department the University of Pennsylvania’s Perelman School of Medicine from 2005 to 2014. The American Society for Radiation Oncology and several other groups expressed their support for Hahn’s nomination on Friday…